Modern approaches to lymphatic surgery: a narrative review.

Emily A Zurbuchen, Nina Yu, Ara A Salibian
{"title":"Modern approaches to lymphatic surgery: a narrative review.","authors":"Emily A Zurbuchen, Nina Yu, Ara A Salibian","doi":"10.21037/tbcr-24-49","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Lymphedema is a chronic, progressive disease secondary to damage to the lymphatic system that results in interstitial fluid accumulation, fat deposition and inflammation. Lymphatic surgery includes a spectrum of procedures aimed to treat these sequelae of lymphedema as well as decrease the risk of lymphedema if performed as prophylactic surgery. We reviewed the literature regarding current surgical treatment options for lymphedema, imaging approaches, and directions the field may head towards both in treatment access and techniques.</p><p><strong>Methods: </strong>We systematically reviewed PubMed, Embase, and Cochrane Library databases to identify approaches to surgical management of lymphedema, including physiologic and reductive methods, as well as challenges that lymphedema patients face for adequate access and insurance coverage to surgical treatment options.</p><p><strong>Key content and findings: </strong>Lymphatic surgery can be broadly categorized as physiologic or reductive. Physiologic lymphatic surgery functions to decrease the fluid burden associated with lymphedema and includes lymphovenous bypass as well as vascularized lymph node transplant procedures. Reductive lymphatic surgery reduces the fibroadipose component of lymphedema and include suction lipectomy and excisional procedures. Advances in imaging technology as well as supermicrosurgical techniques have allowed for reproducible, positive clinical outcomes after lymphatic procedures. Access to care and coverage of procedures are persistent challenges in the field, though increasing adoption and research have led to important strides forward to providing patients with this care.</p><p><strong>Conclusions: </strong>Lymphatic surgery can improve symptoms and quality of life for lymphedema patients. A clear understanding of the predominant pathology in a patient (i.e., fluid dominant vs. fat dominant) can help guide counseling and surgical management options for patients. Despite the established benefits for patients, equitable access and insurance coverage for lymphedema surgery are still required.</p>","PeriodicalId":101427,"journal":{"name":"Translational breast cancer research : a journal focusing on translational research in breast cancer","volume":"6 ","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11836749/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational breast cancer research : a journal focusing on translational research in breast cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/tbcr-24-49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: Lymphedema is a chronic, progressive disease secondary to damage to the lymphatic system that results in interstitial fluid accumulation, fat deposition and inflammation. Lymphatic surgery includes a spectrum of procedures aimed to treat these sequelae of lymphedema as well as decrease the risk of lymphedema if performed as prophylactic surgery. We reviewed the literature regarding current surgical treatment options for lymphedema, imaging approaches, and directions the field may head towards both in treatment access and techniques.

Methods: We systematically reviewed PubMed, Embase, and Cochrane Library databases to identify approaches to surgical management of lymphedema, including physiologic and reductive methods, as well as challenges that lymphedema patients face for adequate access and insurance coverage to surgical treatment options.

Key content and findings: Lymphatic surgery can be broadly categorized as physiologic or reductive. Physiologic lymphatic surgery functions to decrease the fluid burden associated with lymphedema and includes lymphovenous bypass as well as vascularized lymph node transplant procedures. Reductive lymphatic surgery reduces the fibroadipose component of lymphedema and include suction lipectomy and excisional procedures. Advances in imaging technology as well as supermicrosurgical techniques have allowed for reproducible, positive clinical outcomes after lymphatic procedures. Access to care and coverage of procedures are persistent challenges in the field, though increasing adoption and research have led to important strides forward to providing patients with this care.

Conclusions: Lymphatic surgery can improve symptoms and quality of life for lymphedema patients. A clear understanding of the predominant pathology in a patient (i.e., fluid dominant vs. fat dominant) can help guide counseling and surgical management options for patients. Despite the established benefits for patients, equitable access and insurance coverage for lymphedema surgery are still required.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
背景和目的:淋巴水肿是一种继发于淋巴系统损伤的慢性、进行性疾病,会导致间质积液、脂肪沉积和炎症。淋巴手术包括一系列旨在治疗淋巴水肿后遗症的手术,如果作为预防性手术,还能降低淋巴水肿的风险。我们回顾了有关当前淋巴水肿手术治疗方案、成像方法以及该领域在治疗途径和技术方面可能发展方向的文献:我们系统地查阅了 PubMed、Embase 和 Cochrane 图书馆数据库,以确定淋巴水肿的手术治疗方法,包括生理学和还原法,以及淋巴水肿患者在获得充分的手术治疗机会和手术治疗选择的保险范围方面所面临的挑战:淋巴手术大致可分为生理性和还原性两种。生理性淋巴手术的作用是减轻与淋巴水肿相关的液体负担,包括淋巴静脉搭桥和血管淋巴结移植手术。还原性淋巴手术可减少淋巴水肿中的纤维脂肪成分,包括吸脂切除术和切除术。成像技术和超显微外科技术的进步使得淋巴手术后的临床效果具有可重复性和积极性。虽然越来越多的人采用淋巴手术并开展相关研究,但为患者提供淋巴手术治疗仍是这一领域长期面临的挑战:淋巴手术可以改善淋巴水肿患者的症状和生活质量。清楚地了解患者的主要病理类型(即液体主导型与脂肪主导型)有助于为患者提供咨询和手术治疗方案。尽管淋巴水肿手术对患者的益处已经得到证实,但仍需要为淋巴水肿手术提供公平的机会和保险保障。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review. Breast cancer shares many epidemiological, lifestyle, and local hormonal and metabolic underpinnings with endometrial and ovarian cancer: a narrative review. De-escalation of axillary treatment in early breast cancer-a narrative review of current trials. DESTINY-Breast06 continues to explore HR+, HER2-negative metastatic breast cancer beyond DESTINY-Breast04. Modern approaches to lymphatic surgery: a narrative review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1